Home » Topics » BioWorld Science

BioWorld Science
RSS

Zinc oxide nanoparticles target integrin alpha-v beta-3 for breast cancer treatment

March 9, 2022

TNIK Therapeutics presents new prodrugs of TNIK inhibitors

March 9, 2022

P2RX3 antagonists discovered at Tuojie Biotech

March 9, 2022

Nanjing Shunxin Pharmaceutical, Jiangsu Chia Tai Tianqing Pharmaceutical Group patent ADCs

March 9, 2022

New ibuprofen derivatives divulged by Nanjing Heron Pharmaceutical Science and Technology

March 9, 2022

Abbisko Therapeutics identifies new EGFR inhibitors

March 9, 2022

Ixaka's CELTIC-19 targeted nanoparticle product granted ATMP classification

March 8, 2022

Sunshine Lake Pharma researchers describe JAK inhibitors

March 8, 2022

Dana-Farber Cancer Institute patents USP28 inhibitors for cancer

March 8, 2022

Bridge signs option agreement for CellionBioMed's ion channel modulator for IPF

March 8, 2022

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...